6-hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells

被引:39
作者
Blum, D
Torch, S
Nissou, MF
Verna, JM
机构
[1] ULB Erasme, Dept Neurosci, Neurophysiol Lab, B-1070 Brussels, Belgium
[2] CHU Michallon, INSERM, Equipe Mixte, F-38043 Grenoble 9, France
[3] Immunol Lab, F-38130 Echirolles, France
关键词
NF-kappaB; PC12; cells; 6-hydroxydopamine; bcl-2; Parkinson's disease;
D O I
10.1016/S0006-2952(01)00680-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The involvement of nuclear Factor-kappaB (NF-kappaB) transcription factor in PC12 cell death triggered by the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) was investigated. Results show that oxidative stress generated by 6-OHDA activates NF-kappaB. When the NF-kappaB activation was inhibited by parthenolide, PC12 cell death induced by 6-OHDA was significantly increased, thus suggesting an involvement of this transcription factor in a protective mechanism against 6-OHDA toxicity. To further assess this hypothesis, we studied the involvement of NF-kappaB in the protective effect of two anti-apoptotic genes, bcl-2 and bfl-1. Although Bcl-2 and Bfl-1 expression normally protects PC12 cells from 6-OHDA, parthenolide strongly decreased the beneficial effects afforded by transgene expression. These results suggest: (1) that the transcription factor NF-kappaB is likely associated with the protection of catecholaminergic PC12 cells and (2) that the protective effects afforded by bcl-2 and bfl-1 expression may be dependent on NF-kappaB activation. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:473 / 481
页数:9
相关论文
共 62 条
[41]   NF-kappa B: A crucial transcription factor for glial and neuronal cell function [J].
ONeill, LAJ ;
Kaltschmidt, C .
TRENDS IN NEUROSCIENCES, 1997, 20 (06) :252-258
[42]   Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide [J].
Patel, NM ;
Nozaki, S ;
Shortle, NH ;
Bhat-Nakshatri, P ;
Newton, TR ;
Rice, S ;
Gelfanov, V ;
Boswell, SH ;
Goulet, RJ ;
Sledge, GW ;
Nakshatri, H .
ONCOGENE, 2000, 19 (36) :4159-4169
[43]  
PerezOtano I, 1996, GLIA, V16, P306, DOI 10.1002/(SICI)1098-1136(199604)16:4<306::AID-GLIA3>3.0.CO
[44]  
2-Y
[45]   REGIONAL EFFECTS OF 6-HYDROXYDOPAMINE (6-OHDA) ON FREE-RADICAL SCAVENGERS IN RAT-BRAIN [J].
PERUMAL, AS ;
TORDZRO, WK ;
KATZ, M ;
JACKSONLEWIS, V ;
COOPER, TB ;
FAHN, S ;
CADET, JL .
BRAIN RESEARCH, 1989, 504 (01) :139-141
[46]  
Piette J, 1997, BIOL CHEM, V378, P1237
[47]   Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum [J].
Qin, ZH ;
Wang, YM ;
Nakai, M ;
Chase, TN .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :33-42
[48]   Oxidative stress interference with the nuclear factor-κB activation pathways [J].
Schoonbroodt, S ;
Piette, J .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1075-1083
[49]   REACTIVE OXYGEN INTERMEDIATES AS APPARENTLY WIDELY USED MESSENGERS IN THE ACTIVATION OF THE NF-KAPPA-B TRANSCRIPTION FACTOR AND HIV-1 [J].
SCHRECK, R ;
RIEBER, P ;
BAEUERLE, PA .
EMBO JOURNAL, 1991, 10 (08) :2247-2258
[50]   Nuclear factor-κB activation in permanent intraluminal focal cerebral ischemia in the rat [J].
Seegers, H ;
Grillon, E ;
Trioullier, Y ;
Väth, A ;
Verna, JM ;
Blum, D .
NEUROSCIENCE LETTERS, 2000, 288 (03) :241-245